CCCA: Central Centrifugal Cicatricial Alopecia Explained

Medically reviewed by Jane Yoo, MD, board-certified dermatologist | Updated November 18th, 2026

Central centrifugal cicatricial alopecia (CCCA) is a scarring form of hair loss. It begins at the crown or mid-scalp and spreads outward in a pattern shaped like a widening circle. It is the most common scarring alopecia in women of African descent, and it is frequently missed or mistaken for something else for years. Because scarring is permanent, early diagnosis and treatment matter more here than almost anywhere else in hair medicine.

What CCCA looks and feels like

  • Thinning at the crown or vertex that slowly widens outward.
  • A smooth, shiny scalp in affected areas where follicle openings have disappeared.
  • Itching, tenderness, tingling, burning or a “crawling” sensation, although some people have no symptoms at all.
  • Small bumps or scale around hairs at the edge of the patch.
  • Hair that breaks easily or looks sparse in the affected area.

The absence of symptoms does not mean the process is quiet. Follicles can be lost without pain.

Why it happens

The exact cause is not fully understood. Inflammation around the follicle damages it and replaces it with scar tissue. For years CCCA was attributed mainly to hot combs, relaxers and tight styles, and it was called “hot comb alopecia”. More recent thinking is that its causes are multifactorial. Genetics play a role: variants in the PADI3 gene have been linked to CCCA in some patients. Hair care practices may contribute, but the evidence tying specific styling practices to CCCA is mixed. A person with CCCA has not necessarily done anything wrong.

How it is diagnosed

  • A clinical exam, including dermoscopy, looking for loss of follicle openings.
  • A history of symptoms, family history and hair care practices.
  • A scalp biopsy, which is often recommended to confirm the diagnosis and rule out other scarring conditions. The biopsy site matters, so it is best done by a clinician who treats hair disease.

Treatment goals

The aim is to stop progression and preserve the follicles that remain. Hair that has been scarred will not regrow, although new thinning can be prevented and some density may return where follicles are still alive.

  • Anti-inflammatory therapy: potent topical corticosteroids, and sometimes steroid injections into the scalp.
  • Oral anti-inflammatory medications, such as doxycycline, used for their anti-inflammatory rather than their antibiotic effect.
  • Topical minoxidil to support remaining hair, as one part of a plan.
  • Gentle hair and scalp care while the disease is active, including avoiding tension, and heat and chemical treatments to the extent you can.
  • Surgery is considered only after the disease has been quiet for a period, and only in carefully selected patients.

Treatment can stabilize CCCA, but it takes patience and follow-up. Many patients need months of treatment before the disease quiets.

How CCCA differs from traction alopecia

  CCCA Traction alopecia
Where it starts Crown or mid-scalp Hairline, temples, edges
Main cause Inflammation and scarring, with genetic and other factors Repeated tension on hair
Reversible? Scarred areas do not regrow

Reversible early, can scar late

Core treatment Anti-inflammatory therapy to stop progression Remove tension, support regrowth

The two can coexist. A dermatologist can tell them apart.

When to see a dermatologist

See a dermatologist as soon as you notice crown thinning, a smooth patch, or an itchy or tender scalp, especially if relatives have had similar hair loss. Waiting often means losing follicles that could have been saved. Ideally, choose a dermatologist experienced in hair disorders in skin of color.

—

Frequently asked questions

Is CCCA reversible?

Areas that have fully scarred will not regrow. Early treatment can stop the disease from spreading and preserve the hair that remains.

Is CCCA caused by relaxers or hot combs?

The causes are likely multifactorial, including genetics. Hair care practices may contribute, but the evidence is mixed, and CCCA can occur without them.

Do I need a biopsy for CCCA?

A biopsy is often recommended to confirm the diagnosis and rule out other scarring conditions. Your dermatologist will decide based on your exam.

—

Concerned about hair thinning or shedding? Dr. Jane Yoo is a board-certified dermatologist in Midtown Manhattan. A proper diagnosis comes first, because the right treatment depends on the type of hair loss. Book a consultation.

This article is for educational purposes and does not replace an in-person medical evaluation.

author avatar
Dr. Jane Yoo Board-Certified Dermatologist and Mohs Surgeon
Jane Yoo, MD, MPP, is a Korean American board-certified dermatologist and fellowship-trained Mohs surgeon based in Midtown Manhattan. She is a Clinical Assistant Professor at the Icahn School of Medicine at Mount Sinai and the founder of Jane Yoo MD, PLLC and the Clinical Research Center of New York. Dr. Yoo holds an undergraduate degree from MIT and a Masters of Public Policy from Harvard's Kennedy School of Government. She completed her Mohs micrographic surgery fellowship at Yale. Her clinical and research focus spans aesthetic clinical trials including injectables and laser technology, skincare formulation and sunscreen science, K-Beauty and skin of color, ultrasound guided filler dissolution, artificial intelligence and beauty tech. Dr. Yoo's research is indexed under ORCID 0000-0002-7112-8963.